SZ
StageZero Life Sciences Ltd.
SZLSF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $630.0K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.17x
EV/FFO N/A
P/E N/A
Growth
100 /100
Growing Rev. growth 201.33%
Book val. growth N/A
EPS growth N/A
Profitability
0 /100
Weak Op. margin 204.13%
Gross margin 10.64%
FCF margin 92.98%
Quality
79 /100
Excellent Asset turnover 5.42x
ROIC 151.85%
ROA 1,629.25%
Debt
50 /100
Moderate Net debt/EBITDA -0.17x
Current ratio 0.04x
Int. coverage -37.63x
Stability
35 /100
Moderate EPS volatility 21.89%
Beta 0.34x
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o SZLSF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James R. Howard-Tripp
Employees
40
Headquarters
Richmond Hill
Nadchodzące wydarzenia
18 LIS
Earnings
Upcoming earnings report